Position in MRK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$5,552,742
+$239,172 QoQ
Shares Held
43,212
-2.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#995
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Essex Financial Services, Inc. holds $71,369,097 across 13 Drug Manufacturers - General names. MRK ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,725 | $27,257,049 | |
| 2 | JNJ |
Johnson & Johnson
|
60,120 | $15,268,676 | |
| 3 | ABBV |
AbbVie Inc.
|
35,746 | $8,995,123 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
43,212 | $5,552,742 | |
| 5 | PFE |
Pfizer Inc
|
185,560 | $4,468,284 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
51,332 | $2,957,749 | |
| 7 | AMGN |
Amgen Inc
|
6,773 | $2,452,638 | |
| 8 | NVS |
Novartis AG
|
8,976 | $1,406,718 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,552,742 | 43,212 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $5,313,570 | 44,173 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $4,600,598 | 43,707 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $3,548,812 | 42,283 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $3,063,175 | 38,696 | Shares | Defined | 2025-07-16 | |
| 2025-03-31 | $3,456,298 | 38,506 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $4,026,651 | 40,477 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $4,408,058 | 38,817 | Shares | Defined | 2024-10-24 | |
| 2024-06-30 | $5,786,535 | 46,741 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $5,024,260 | 38,077 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $4,013,789 | 36,817 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,767,867 | 36,599 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $4,301,623 | 37,279 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $4,094,206 | 38,483 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,325,718 | 38,988 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,280,396 | 38,091 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $3,349,129 | 36,735 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $2,947,810 | 35,927 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $3,023,984 | 39,457 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,940,781 | 39,153 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,292,970 | 29,484 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $2,272,922 | 29,484 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $2,493,099 | 30,478 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $2,651,912 | 31,970 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $2,127,503 | 27,512 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $2,322,586 | 30,187 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||